Cargando…

Targeting Vessel Formation in Pulmonary Arterial Hypertension: Is the Endostatin–Id1–Thrombospondin 1 Pathway a New Hope?

Detalles Bibliográficos
Autor principal:	Rhodes, Christopher J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110980/ https://www.ncbi.nlm.nih.gov/pubmed/32049569 http://dx.doi.org/10.1165/rcmb.2020-0012ED

Ejemplares similares

Endostatin in the pancreas
por: Wigmore, S J
Publicado: (2005)

The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension
por: Simpson, Catherine E., et al.
Publicado: (2021)

Relationship between thrombospondin-1, endostatin, angiopoietin-2, and coronary collateral development in patients with chronic total occlusion
por: Qin, Qing, et al.
Publicado: (2016)

The role of circulating thrombospondin-1 in patients with precapillary pulmonary hypertension
por: Kaiser, Ralf, et al.
Publicado: (2016)

Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension
por: Ochoa, Cristhiaan D, et al.
Publicado: (2010)

Endostatin and ST2 are predictors of pulmonary hypertension disease course in infants.
por: Griffiths, Megan, et al.
Publicado: (2020)

Endostatin as a Biomarker of Basement Membrane Degradation
por: Sato, Yasufumi
Publicado: (2017)

COL18A1 genotypic associations with endostatin levels and clinical features in pulmonary arterial hypertension: a quantitative trait association study
por: Simpson, Catherine E., et al.
Publicado: (2022)

Retinal vessel changes in pulmonary arterial hypertension
por: DuPont, Mariana, et al.
Publicado: (2022)

New hope for a microRNA therapy for pulmonary arterial hypertension
por: Mehta, Jyoti, et al.
Publicado: (2013)

New hope for Nutlin-3a therapy for pulmonary arterial hypertension
por: Fukumoto, Jutaro, et al.
Publicado: (2013)

Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease–Associated Pulmonary Hypertension
por: Daly, Caroline M., et al.
Publicado: (2021)

What is pulmonary arterial hypertension?
por: Rich, Stuart
Publicado: (2012)

The revolution of pulmonary arterial hypertension
por: Harari, Sergio
Publicado: (2016)

Role of thrombospondin-1 and thrombospondin-2 in cardiovascular diseases (Review)
por: Zhang, Kaijie, et al.
Publicado: (2020)

TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension
por: Kumar, Rahul, et al.
Publicado: (2017)

Effect of Transcriptional Regulator ID3 on Pulmonary Arterial Hypertension and Hereditary Hemorrhagic Telangiectasia
por: Avecilla, Vincent
Publicado: (2019)

Breathing Hope into Directed Therapy for Pulmonary Infections
por: Waterer, Grant
Publicado: (2021)

Increased plasma expression of a disintegrin and metalloproteinase with thrombospondin motifs like 4 in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Li, Yan, et al.
Publicado: (2023)

Schedule H1: Hope or hype?
por: Hazra, Avijit
Publicado: (2014)

A Role for Syndecan-1 in Coupling Fascin Spike Formation by Thrombospondin-1
por: Adams, Josephine C., et al.
Publicado: (2001)

Hypertensive Patients Exhibit Enhanced Thrombospondin-1 Levels at High-Altitude
por: Sharma, Kavita, et al.
Publicado: (2021)

In Defense of the Nucleus: NUDT1 and Oxidative DNA Damage in Pulmonary Arterial Hypertension
por: Agarwal, Stuti, et al.
Publicado: (2021)

Endostatin and Vascular Endothelial Growth Factor-A(165)b May Contribute to Classification of Pulmonary Hypertension
por: Adachi, Shiro, et al.
Publicado: (2021)

Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog
por: Wang, Shan, et al.
Publicado: (2016)

In vivo expression of thrombospondin-1 suppresses the formation of peritoneal adhesion in rats
por: Tai, Yun-Sheng, et al.
Publicado: (2019)

TGF-β promotes microtube formation in glioblastoma through thrombospondin 1
por: Joseph, Justin V, et al.
Publicado: (2021)

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension
por: Weatherald, Jason, et al.
Publicado: (2023)

Thrombospondin-1 in Early Flow-Related Remodeling of Mesenteric Arteries from Young Normotensive and Spontaneously Hypertensive Rats
por: Lemkens, P, et al.
Publicado: (2012)

Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma
por: Straume, O, et al.
Publicado: (2005)

Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension
por: Tang, Haiyang, et al.
Publicado: (2017)

mTORC1 in Pulmonary Arterial Hypertension. At the Crossroads between Vasoconstriction and Vascular Remodeling?
por: Goncharova, Elena A., et al.
Publicado: (2020)

EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition
por: Pullamsetti, Soni Savai, et al.
Publicado: (2019)

Thrombospondin 1 in Metabolic Diseases
por: Gutierrez, Linda S., et al.
Publicado: (2021)

Serum angiostatin and endostatin levels in patients with granulomatosis with polyangiitis and immune complex small vessel vasculitis
por: Kotulska-Kucharz, Anna, et al.
Publicado: (2018)

Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome
por: Bachelot, T, et al.
Publicado: (2006)

Recent advances in pulmonary arterial hypertension
por: Wilkins, Martin R., et al.
Publicado: (2018)

New Therapeutic Target for Pulmonary Arterial Hypertension
por: Yoon, Kyung Lim
Publicado: (2018)

A Plot TWIST in Pulmonary Arterial Hypertension
por: Misner, Kevin, et al.
Publicado: (2020)

Deconstructing the Melting Pot in Pulmonary Arterial Hypertension
por: Austin, Eric D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gvop4d4pebta4pa9nh0guer8ba